Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
PLoS One ; 4(4): e5354, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19399181

RESUMEN

BACKGROUND: Wnt5a is a member of the wingless-type patterning regulators important in pre-natal development. The expression and distribution of Wnt5a and its receptors frizzled (fzd) 3 and fzd 5 in adult human skin have not been comprehensively studied to date. METHODOLOGY/PRINCIPAL FINDINGS: We here show that Wnt5a, fzd3, fzd5, as well as fzd6 are restricted to specific layers in normal epidermis, analogous to their zonal distribution in hair follicles, suggesting a role in adult skin differentiation. In line, Wnt5a and fzd5 are both overexpressed and re-distributed in the epidermis of psoriasis which involves disturbed keratinocyte differentiation. Functionally, Wnt5a lowers the concentration of IFN required to induce target genes, and increases the magnitude of IFN target gene induction, suggesting a molecular mechanism underlying IFN hypersensitivity in psoriasis. Finally, we identify nedd8 and the amyloid precursor APP, previously shown to be upregulated in psoriasis, as targets of synergistic IFNalpha/Wnt5a induction. CONCLUSIONS/SIGNIFICANCE: The present data (i) suggest that Wnt5a regulates epidermal differentiation even in adult skin and (ii) identify synergistic induction of type 1 IFN target genes as a novel mode of Wnt5a action. Targeting Wnt5a in the skin may reduce IFN hypersensitivity and be of therapeutical value.


Asunto(s)
Interferón Tipo I/genética , Interferón Tipo I/metabolismo , Proteínas Proto-Oncogénicas/genética , Proteínas Proto-Oncogénicas/metabolismo , Psoriasis/genética , Psoriasis/metabolismo , Piel/metabolismo , Proteínas Wnt/genética , Proteínas Wnt/metabolismo , Adulto , Precursor de Proteína beta-Amiloide/biosíntesis , Células Cultivadas , Receptores Frizzled/genética , Receptores Frizzled/metabolismo , Expresión Génica , Humanos , Interferón Tipo I/farmacología , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Proteína NEDD8 , Nexinas de Proteasas , Psoriasis/patología , Receptores de Superficie Celular/biosíntesis , Proteínas Recombinantes , Piel/anatomía & histología , Piel/efectos de los fármacos , Distribución Tisular , Transfección , Ubiquitinas/biosíntesis , Regulación hacia Arriba , Proteína Wnt-5a
2.
J Invest Dermatol ; 128(1): 110-24, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17637826

RESUMEN

Psoriasis is a common skin disease involving keratinocyte proliferation and altered differentiation, as well as T-cell activation. Here, we show that altered gene transcription in psoriatic skin lesions is highly reproducible between independent data sets. Analysis of gene expression confirmed dysregulation in all expected functional categories, such as IFN signaling and keratinocyte differentiation, and allowed molecular fingerprinting of a previously characterized dendritic cell subset associated with psoriasis tumor necrosis factor alpha (TNF-alpha)- and inducible nitric oxide synthase (iNOS)-producing CD11b(INT) DC (Tip-DC). Unexpectedly, a large group of dysregulated transcripts was related to fatty acid signaling and adipocyte differentiation, exhibiting a pattern consistent with the activation of peroxisome proliferator-activated receptor delta (PPARdelta). PPARdelta itself was strongly induced in psoriasis in vivo. In primary keratinocytes, PPARdelta was induced by the transcription factor activator protein 1, in particular by junB, but not by canonical WNT signaling, in contrast to its regulation in colon carcinoma cells. Activation of PPARdelta enhanced proliferation of keratinocytes, while this was inhibited by knockdown of PPARdelta. Finally, heparin-binding EGF-like growth factor (HB-EGF), known to induce epidermal hyperplasia and itself overexpressed in psoriasis, was identified as a direct target gene of PPARdelta. The present data suggest that activation of PPARdelta is a major event in psoriasis, contributing to the hyperproliferative phenotype by induction of HB-EGF.


Asunto(s)
Péptidos y Proteínas de Señalización Intercelular/genética , Queratinocitos/patología , PPAR delta/fisiología , Psoriasis/metabolismo , Proliferación Celular , Células Cultivadas , Células Dendríticas/metabolismo , Ácidos Grasos/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Factor de Crecimiento Similar a EGF de Unión a Heparina , Humanos , FN-kappa B/análisis , PPAR delta/análisis , Isoformas de Proteínas , Psoriasis/genética , Psoriasis/patología , Transducción de Señal , Factor de Transcripción AP-1/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA